Piper Jaffray Initiates Avalanche Biotechnologies At Overweight

by Monica Gerson, Benzinga Staff Writer

August 25, 2014 7:00 AM | 12 seconds read | Make a Comment

Analysts at Piper Jaffray initiated coverage on Avalanche Biotechnologies

AAVL

with a Overweight rating. The target price for Avalanche Biotechnologies is set to $39. Avalanche Biotechnologies' shares surged 1.23% to close at $30.52 on Friday.

Market News and Data brought to you by Benzinga APIs

Posted In: Initiation Analyst Ratings Piper Jaffray

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Piper Jaffray Initiates Avalanche Biotechnologies At Overweight